Li Yang, Liuyin Zhou, Chaofu Zhao, Lingdan Lan, Chao Ji, Jianfei Tu, Weidan Xu
{"title":"Analysis of Current Status and Influencing Factors of Psychological Distress Tolerance in Liver Cancer Patients after Interventional Therapy.","authors":"Li Yang, Liuyin Zhou, Chaofu Zhao, Lingdan Lan, Chao Ji, Jianfei Tu, Weidan Xu","doi":"10.5152/pcp.2024.24956","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Interventional therapy, currently, has become a major method for the clinical treatment of liver cancer patients. However, interventional therapy can also lead to various toxic side effects, and combined with the impact of the disease itself, liver cancer patients often experience more severe emotional distress. Improving individuals' levels of psychological distress tolerance may reduce sensitivity to negative life events and experiences. At this stage, there is no relevant literature reporting on the psychological distress tolerance of liver cancer patients after interventional therapy. This study investigates and analyzes psychological distress tolerance in liver cancer patients after interventional therapy, aiming to optimize personalized nursing interventions and improve patients' long-term quality of life.</p><p><strong>Methods: </strong>This study is a cross-sectional study. Convenience sampling is adopted. Liver cancer patients who underwent interventional therapy in our hospital from August 2023 to May 2024 were selected. General Information Questionnaire, Psychological Distress Tolerance Scale, Psychological Resilience Scale, Fear of Progression Questionnaire-Short Form, and Perceived Social Support Scale were used for data collection. Multiple linear regression analysis was performed to identify the influencing factors of psychological distress tolerance in liver cancer patients after interventional therapy.</p><p><strong>Results: </strong>The total score of psychological distress tolerance in 157 liver cancer patients was 26.88 ± 4.15, with item scores for each dimension ranging from low to high, namely, pain endurance and pain management. The results of multiple linear regression analysis showed that age, tumor size, number of tumors, psychological resilience, fear of disease progression, and perceived social support were influencing factors of psychological distress tolerance in liver cancer patients after interventional therapy (P < .05).</p><p><strong>Conclusion: </strong>The level of psychological distress tolerance in liver cancer patients after interventional therapy needs to be improved, and it is relevant to age, tumor size, number of tumors, psychological resilience, fear of disease progression, and perceived social support.</p>","PeriodicalId":20847,"journal":{"name":"Psychiatry and Clinical Psychopharmacology","volume":"34 4","pages":"342-348"},"PeriodicalIF":0.5000,"publicationDate":"2024-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11744382/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychiatry and Clinical Psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5152/pcp.2024.24956","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Interventional therapy, currently, has become a major method for the clinical treatment of liver cancer patients. However, interventional therapy can also lead to various toxic side effects, and combined with the impact of the disease itself, liver cancer patients often experience more severe emotional distress. Improving individuals' levels of psychological distress tolerance may reduce sensitivity to negative life events and experiences. At this stage, there is no relevant literature reporting on the psychological distress tolerance of liver cancer patients after interventional therapy. This study investigates and analyzes psychological distress tolerance in liver cancer patients after interventional therapy, aiming to optimize personalized nursing interventions and improve patients' long-term quality of life.
Methods: This study is a cross-sectional study. Convenience sampling is adopted. Liver cancer patients who underwent interventional therapy in our hospital from August 2023 to May 2024 were selected. General Information Questionnaire, Psychological Distress Tolerance Scale, Psychological Resilience Scale, Fear of Progression Questionnaire-Short Form, and Perceived Social Support Scale were used for data collection. Multiple linear regression analysis was performed to identify the influencing factors of psychological distress tolerance in liver cancer patients after interventional therapy.
Results: The total score of psychological distress tolerance in 157 liver cancer patients was 26.88 ± 4.15, with item scores for each dimension ranging from low to high, namely, pain endurance and pain management. The results of multiple linear regression analysis showed that age, tumor size, number of tumors, psychological resilience, fear of disease progression, and perceived social support were influencing factors of psychological distress tolerance in liver cancer patients after interventional therapy (P < .05).
Conclusion: The level of psychological distress tolerance in liver cancer patients after interventional therapy needs to be improved, and it is relevant to age, tumor size, number of tumors, psychological resilience, fear of disease progression, and perceived social support.
期刊介绍:
Psychiatry and Clinical Psychopharmacology aims to reach a national and international audience and will accept submissions from authors worldwide. It gives high priority to original studies of interest to clinicians and scientists in applied and basic neurosciences and related disciplines. Psychiatry and Clinical Psychopharmacology publishes high quality research targeted to specialists, residents and scientists in psychiatry, psychology, neurology, pharmacology, molecular biology, genetics, physiology, neurochemistry, and related sciences.